Other

Valeant to buy Bausch + Lomb for $8.7B (Update)

Canadian drugmaker Valeant Pharmaceuticals said Monday that it will pay $8.7 billion to buy Bausch + Lomb, one of the world's best-known makers of contact lenses, in a massive expansion of Valeant's smaller ophthalmology ...

Medications

Drug sales to hit lowest growth rate in decades

Growth in global prescription drug spending will slow to the lowest rate in decades as low-cost generic drugs continue replacing former blockbusters in the U.S. and Europe, where governments face new pressure to reduce health ...

Medications

China to allow some drugs based on foreign approvals

China will allow use of some drugs and medical devices based on approval by foreign regulators, the government said Monday, in a move that could help to ease access to its health care market.

Health

FDA brings e-cigarettes under federal authority

Hundreds of electronic cigarette brands will have to undergo federal review to stay on the market under new rules that have the potential to upend a multi-billion dollar industry attempting to position itself as an alternative ...

page 12 from 14